| RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension (NCT01756300) | Biosense Webster, Inc. | 2012-12-01 |
| Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin (NCT01723527) | Johns Hopkins University | 2012-12-01 |
| Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of Simotinib Hydrochloride in Patients With Advanced NSCLC (NCT01772732) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2012-12-01 |
| A Bioequivalence Study of Capecitabine Tablets (NCT01846650) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2012-12-01 |
| A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers (NCT01749098) | Biogen | 2012-12-01 |
| Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis (NCT01758510) | Hanyang University Seoul Hospital | 2012-12-01 |
| Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients (NCT01690403) | Sanofi | 2012-12-01 |
| A Phase 1 Study of MORAb-004 in Patients With Solid Tumor (Study: MORAb-004-J081-103) (NCT01773434) | Eisai Co., Ltd. | 2012-12-01 |
| Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas (NCT01799083) | Han weidong | 2012-12-01 |
| Antigen-specific Cancer Immunotherapy (TG01) and Gemcitabine as Adjuvant Therapy in Resected Pancreatic Cancer (NCT02261714) | Targovax ASA | 2012-12-01 |
| Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma (NCT01757626) | Memorial Sloan Kettering Cancer Center | 2012-12-01 |
| A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) (NCT01688791) | Endocyte | 2012-12-01 |
| Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin (NCT01863004) | University Hospital, Basel, Switzerland | 2012-12-01 |
| Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults (NCT01771848) | Sanaria Inc. | 2012-12-01 |
| Redirected MazF-CD4 Autologous T Cells for HIV Gene Therapy (NCT01787994) | University of Pennsylvania | 2012-12-01 |
| A Crossover Study to Assess the Bioequivalence of Hydrocodone Bitartrate Extended-Release Tablet (NCT01758978) | Teva Branded Pharmaceutical Products R&D, Inc. | 2012-12-01 |
| Primaquine Pharmacokinetics in Lactating Women and Their Infants (NCT01780753) | University of Oxford | 2012-12-01 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants (NCT01780259) | Janssen Research & Development, LLC | 2012-12-01 |
| A Single Dose Study of LY2605541 in Participants With Liver Impairment (NCT01751399) | Eli Lilly and Company | 2012-12-01 |
| A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants (NCT01763021) | Janssen Research & Development, LLC | 2012-12-01 |
| Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients (NCT01746654) | GangaGen, Inc. | 2012-12-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects (NCT01751269) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-12-01 |
| A Study of Evacetrapib in Healthy Female Participants (NCT01746732) | Eli Lilly and Company | 2012-12-01 |
| Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients (NCT01802970) | Baylor Research Institute | 2012-12-01 |
| Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT (NCT01822093) | Cell Medica Ltd | 2012-12-01 |
| ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA (NCT01730612) | Nantes University Hospital | 2012-12-01 |
| Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease (NCT01754454) | Affiliated Hospital to Academy of Military Medical Sciences | 2012-12-01 |
| Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 (NCT01748838) | Celtaxsys, Inc. | 2012-12-01 |
| A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adult Male Volunteers (NCT01925313) | HK inno.N Corporation | 2012-12-01 |
| Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue (NCT03629847) | King Faisal Specialist Hospital & Research Center | 2012-12-01 |
| Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy (NCT01739777) | Universidad de los Andes, Chile | 2012-12-01 |
| The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia (NCT01654562) | University of Alberta | 2012-12-01 |
| Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation (NCT01758367) | Chinese PLA General Hospital | 2012-12-01 |
| Proton or Photon RT for Retroperitoneal Sarcomas (NCT01659203) | Massachusetts General Hospital | 2012-12-01 |
| Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity (NCT01760642) | Seoul National University Hospital | 2012-12-01 |
| Use of Prokinetics During Inpatient Bowel Care for SCI Patients (NCT02370433) | James J. Peters Veterans Affairs Medical Center | 2012-12-01 |
| Study of Simmitecan Hydrochloride in the Treatment of Advanced Solid Tumor (NCT01832298) | Haihe Biopharma Co., Ltd. | 2012-12-01 |
| A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects (NCT01762995) | ViiV Healthcare | 2012-12-01 |
| Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg (NCT01806311) | HanAll BioPharma Co., Ltd. | 2012-12-01 |
| Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects (NCT01737424) | LG Life Sciences | 2012-12-01 |
| CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome (NCT03393611) | Weill Medical College of Cornell University | 2012-11-30 |
| Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123 (NCT02278198) | University of Colorado, Denver | 2012-11-30 |
| Oral Bioavailability and Mass Balance Trial With Pimasertib (NCT01713036) | Merck KGaA, Darmstadt, Germany | 2012-11-30 |
| Deep Brain Stimulation for Refractory Alcoholism (NCT01798888) | National Institute of Neurological Disorders and Stroke (NINDS) | 2012-11-30 |
| A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (NCT01685892) | Genentech, Inc. | 2012-11-29 |
| An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies (NCT01677780) | Hoffmann-La Roche | 2012-11-28 |
| Study of the Safety, Tolerability and Immunogenicity of an Intranasal Influenza Vaccine Administered to Healthy Adults (NCT03293732) | Advagene Biopharma Co. Ltd. | 2012-11-28 |
| Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG) (NCT01644773) | St. Jude Children's Research Hospital | 2012-11-27 |
| A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors (NCT01708161) | Novartis Pharmaceuticals | 2012-11-27 |
| Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer (NCT01740648) | Ohio State University Comprehensive Cancer Center | 2012-11-26 |
| Phase I Clinical and Pharmacokinetic Study of Pazopanib in a Population of Frail Elderly Patients According SIOG Criteria (NCT01642017) | Institut Claudius Regaud | 2012-11-22 |
| Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study (NCT02028949) | Centre Hospitalier Universitaire Dijon | 2012-11-22 |
| Allogeneic Stem Cell Transplant for CLL (NCT01629511) | M.D. Anderson Cancer Center | 2012-11-21 |
| Open Label Study of BAY1082439 in Patients With Advanced Cancer (NCT01728311) | Bayer | 2012-11-21 |
| Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer (NCT01684397) | Roswell Park Cancer Institute | 2012-11-21 |
| Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies (NCT01744912) | TG Therapeutics, Inc. | 2012-11-21 |
| Tosedostat and Cytarabine or Azacitidine in Treating Older Participants With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT01636609) | M.D. Anderson Cancer Center | 2012-11-20 |
| A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard Therapy (NCT01794507) | AbbVie | 2012-11-19 |
| Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma (NCT01729806) | National Cancer Institute (NCI) | 2012-11-19 |
| Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors (NCT01713972) | Manisha Shah | 2012-11-19 |
| Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets) (NCT01748812) | National Institute of Dental and Craniofacial Research (NIDCR) | 2012-11-16 |
| Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency (NCT01380990) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2012-11-15 |
| Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B (NCT02881008) | Hepatera Ltd. | 2012-11-14 |
| A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus (NCT03202875) | Sanofi | 2012-11-14 |
| Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients (NCT01723514) | Amgen | 2012-11-14 |
| Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors (NCT01709435) | National Cancer Institute (NCI) | 2012-11-14 |
| Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease (NCT01680965) | H. Lee Moffitt Cancer Center and Research Institute | 2012-11-14 |
| Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (NCT01458405) | Capricor Inc. | 2012-11-13 |
| A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT01602315) | Novartis Pharmaceuticals | 2012-11-12 |
| Community Intervention to Prevent Nipah Spillover (NCT01811784) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2012-11-10 |
| Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma (NCT01703507) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-11-09 |
| Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function (NCT01732263) | Shire | 2012-11-09 |
| Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma (NCT01476839) | City of Hope Medical Center | 2012-11-09 |
| To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI) (NCT01725685) | GlaxoSmithKline | 2012-11-08 |
| Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C (NCT01760187) | Aegerion Pharmaceuticals, Inc. | 2012-11-07 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection (NCT01740791) | Gilead Sciences | 2012-11-06 |
| Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome (NCT01728922) | University College Dublin | 2012-11-06 |
| Whole Brain Radiotherapy (WBRT) With Sorafenib for Breast Cancer Brain Metastases (BCBM) (NCT01724606) | Memorial Sloan Kettering Cancer Center | 2012-11-05 |
| Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects (NCT01702480) | GlaxoSmithKline | 2012-11-05 |
| First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer (NCT01723475) | Bayer | 2012-11-02 |
| Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (Ronacaleret) (NCT01802892) | GlaxoSmithKline | 2012-11-02 |
| A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease (NCT01733992) | Rigel Pharmaceuticals | 2012-11-01 |
| Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients (NCT01718587) | General Hospital of Chinese Armed Police Forces | 2012-11-01 |
| Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series (NCT01708226) | University of California, Los Angeles | 2012-11-01 |
| Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis (NCT01724788) | Sanofi | 2012-11-01 |
| Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria (NCT02082860) | Digna Biotech S.L. | 2012-11-01 |
| Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC (NCT02724332) | Eastern Hepatobiliary Surgery Hospital | 2012-11-01 |
| Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (NCT01723553) | Mayo Clinic | 2012-11-01 |
| Safety Study of NBP608 in Healthy Adult Volunteers (NCT03121638) | SK Chemicals Co., Ltd. | 2012-11-01 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE) (NCT01686555) | AbbVie (prior sponsor, Abbott) | 2012-11-01 |
| A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131) (NCT01754818) | Stealth BioTherapeutics Inc. | 2012-11-01 |
| Study of LY2157299 in Japanese Participants With Cancer (NCT01722825) | Eli Lilly and Company | 2012-11-01 |
| Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression (NCT01732055) | University of North Carolina, Chapel Hill | 2012-11-01 |
| A Study of Effect of Deodorant and Axillary Hair on Testosterone Absorption in Healthy Participants (NCT01725451) | Eli Lilly and Company | 2012-11-01 |
| A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers (NCT01731327) | Pfizer | 2012-11-01 |
| The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy (NCT01897077) | Johns Hopkins University | 2012-11-01 |
| Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot (NCT01731067) | Jules Desmeules | 2012-11-01 |
| Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects (NCT01760980) | Actavis Inc. | 2012-11-01 |
| Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects. (NCT03572647) | Azidus Brasil | 2012-11-01 |
| Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects (NCT01872013) | Astellas Pharma Inc | 2012-11-01 |